Explore
Validate
Learn
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 21985-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- TRPM4 antibody
- Antibody type
- Polyclonal
- Description
- TRPM4 antibody (Cat. #21985-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Comprehensive bioinformatic analysis reveals TRPM4 as a biomarker for pan-cancer progression and macrophage infiltration.
Inhibition of Transglutaminase 2 Preserves Blood-Brain Barrier Integrity and Improves Neurological Outcomes After Experimental Traumatic Brain Injury in Mice.
Necrosis by sodium overload-associated genes TRPM4 and SLC9A1: biological roles and clinical implications in breast cancer progression.
Comprehensive Insights Into the Role of TRPM4 in Pan-Cancer Progression and Immune Regulation.
Cinobufagin overcomes bortezomib resistance in multiple myeloma strains by targeting SEC62/TRPM4-mediated NECSO.
N-palmitoyl glycine differentially modulates TRPM4 and TRPC5 and is causally linked to Brugada syndrome.
Transient receptor potential channel TRPM4 favors oxidized low-density lipoprotein-induced coronary endothelial cell dysfunction via a mechanism involving ferroptosis.
Identification of a 24-gene panel and a novel marker of PODXL2 essential for the pathological diagnosis of early prostate cancer.
Huang X, Hong M, Gu L, Zhang X, Feng P, Hu R
Discover oncology 2026 Mar 11;17(1)
Discover oncology 2026 Mar 11;17(1)
Inhibition of Transglutaminase 2 Preserves Blood-Brain Barrier Integrity and Improves Neurological Outcomes After Experimental Traumatic Brain Injury in Mice.
Yang J, Zhang L, Qiu X, Wang J, Yan R, Ye J, Peng J, Jiang Y
CNS neuroscience & therapeutics 2026 Apr;32(4):e70887
CNS neuroscience & therapeutics 2026 Apr;32(4):e70887
Necrosis by sodium overload-associated genes TRPM4 and SLC9A1: biological roles and clinical implications in breast cancer progression.
Zhu Y, Guo Y, Su Y, Zhang Z, Lu Y, Zhang X, Pang H
Frontiers in immunology 2025;16:1623511
Frontiers in immunology 2025;16:1623511
Comprehensive Insights Into the Role of TRPM4 in Pan-Cancer Progression and Immune Regulation.
Chang W, Gao W, Luo B, Chen Y, Wen Z
ImmunoTargets and therapy 2025;14:831-848
ImmunoTargets and therapy 2025;14:831-848
Cinobufagin overcomes bortezomib resistance in multiple myeloma strains by targeting SEC62/TRPM4-mediated NECSO.
Yin Z, Li G, Zhong Q, Zhang X, Ou R, Shen H, Huang J, Mahati S, Liu Z, Zhu Y, Zhang Q, Liu S
Phytomedicine : international journal of phytotherapy and phytopharmacology 2025 Nov;147:157171
Phytomedicine : international journal of phytotherapy and phytopharmacology 2025 Nov;147:157171
N-palmitoyl glycine differentially modulates TRPM4 and TRPC5 and is causally linked to Brugada syndrome.
Xu H, Li B, Chen Y, Lin Y, Zhang A, Wu L
Communications biology 2025 Nov 28;8(1):1854
Communications biology 2025 Nov 28;8(1):1854
Transient receptor potential channel TRPM4 favors oxidized low-density lipoprotein-induced coronary endothelial cell dysfunction via a mechanism involving ferroptosis.
Ye F, Liu D, Zhang J
Tissue & cell 2024 Feb;86:102290
Tissue & cell 2024 Feb;86:102290
Identification of a 24-gene panel and a novel marker of PODXL2 essential for the pathological diagnosis of early prostate cancer.
Ma X, Chen L, Chen T, Chen K, Zhang H, Huang K, Zheng H, Jin H, Cheng Z, Xiao K, Guo J
Computational and structural biotechnology journal 2023;21:5476-5490
Computational and structural biotechnology journal 2023;21:5476-5490
No comments: Submit comment
No validations: Submit validation data